Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
ANI PHARMACEUTICALS INC (ANIP)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Drug Manufacturers—Specialty & Generic
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
5 Mar 2024
Mutz Christopher
HEAD OF RARE DISEASE, Officer
ANI PHARMACEUTICALS INC
(ANIP)
87,387
-5%
5,000
$66.00
$330,000.00
SELL
4 Mar 2024
Pera Antonio R
Director
ANI PHARMACEUTICALS INC
(ANIP)
26,627
-20%
7,000
$65.20
$456,399.97
SELL
13 Feb 2024
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC., Officer
ANI PHARMACEUTICALS INC
(ANIP)
36,799
-0%
250
$56.04
$14,010.00
SELL
19 Jan 2024
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
882,620
-2%
25,216
$56.17
$1,416,466.00
SELL
16 Jan 2024
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
907,836
-2%
24,784
$55.29
$1,370,305.20
SELL
12 Jan 2024
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC., Officer
ANI PHARMACEUTICALS INC
(ANIP)
37,049
-0%
250
$56.43
$14,107.50
SELL
15 Dec 2023
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
932,620
-5%
50,000
$52.55
$2,627,250.00
SELL
15 Nov 2023
Davis Krista
SVP, CHIEF HR OFFICER, Officer
ANI PHARMACEUTICALS INC
(ANIP)
32,587
-7%
2,622
$53.81
$141,089.83
SELL
14 Nov 2023
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
996,430
-3%
36,190
$53.00
$1,918,080.00
SELL
10 Nov 2023
Mutz Christopher
HEAD OF RARE DISEASE, Officer
ANI PHARMACEUTICALS INC
(ANIP)
63,607
-4%
3,000
$52.47
$157,410.00
SELL
15 Sep 2023
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
1,082,620
-4%
50,000
$61.81
$3,090,616.50
SELL
1 Sep 2023
Gassert Chad
SVP - CORP. DEV. & STRATEGY, Officer
ANI PHARMACEUTICALS INC
(ANIP)
313,226
-6%
20,000
$64.70
$1,294,000.00
SELL
28 Aug 2023
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
1,132,620
-4%
50,000
$63.22
$3,160,750.00
SELL
23 Aug 2023
Marken James G.
SVP OPS & PROD DEV, Officer
ANI PHARMACEUTICALS INC
(ANIP)
133,112
-2%
3,932
$63.00
$247,716.00
SELL
23 Aug 2023
Gutwerg Ori
SVP, GENERICS, Officer
ANI PHARMACEUTICALS INC
(ANIP)
62,974
-19%
15,561
$62.39
$970,850.75
SELL
16 Aug 2023
MERIDIAN VENTURE PARTNERS II LP
10% Owner
ANI PHARMACEUTICALS INC
(ANIP)
1,819,259
-9%
200,000
$58.50
$11,700,000.00
SELL
14 Aug 2023
Pera Antonio R
Director
ANI PHARMACEUTICALS INC
(ANIP)
33,627
-8%
3,000
$60.37
$181,110.00
SELL
14 Aug 2023
CAREY STEPHEN P.
SVP & CFO, Officer
ANI PHARMACEUTICALS INC
(ANIP)
155,839
-10%
17,639
$61.37
$1,082,505.40
SELL
14 Aug 2023
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
1,182,620
-4%
50,000
$61.35
$3,067,449.50
SELL
11 Aug 2023
Lalwani Nikhil
PRESIDENT & CEO, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
353,390
-16%
68,282
$58.33
$3,982,547.50
SELL
1 Aug 2023
Gassert Chad
SVP - CORP. DEV. & STRATEGY, Officer
ANI PHARMACEUTICALS INC
(ANIP)
333,226
-5%
20,000
$51.06
$1,021,200.00
SELL
14 Jul 2023
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
1,256,089
-2%
26,531
$51.02
$1,353,598.90
SELL
3 Jul 2023
Gassert Chad
SVP - CORP. DEV. & STRATEGY, Officer
ANI PHARMACEUTICALS INC
(ANIP)
353,226
-5%
20,000
$53.43
$1,068,600.00
SELL
22 Jun 2023
Gassert Chad
SVP - CORP. DEV. & STRATEGY, Officer
ANI PHARMACEUTICALS INC
(ANIP)
373,226
-5%
20,000
$51.32
$1,026,400.00
SELL
20 Jun 2023
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
7,407
-84%
40,000
$51.75
$2,070,011.90
SELL
20 Jun 2023
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
1,282,620
-3%
50,000
$51.70
$2,584,912.00
SELL
1 Dec 2022
MERIDIAN VENTURE PARTNERS II LP
10% Owner
ANI PHARMACEUTICALS INC
(ANIP)
2,019,259
-9%
200,000
$38.50
$7,700,000.00
SELL
12 Aug 2022
Marken James G.
SVP OPS & PROD DEV, Officer
ANI PHARMACEUTICALS INC
(ANIP)
117,642
-13%
18,066
$37.26
$673,069.25
BUY
21 Mar 2022
Walsh Patrick D
Director
ANI PHARMACEUTICALS INC
(ANIP)
53,388
+10%
5,000
$27.76
$138,794.00
BUY
21 Mar 2022
Lalwani Nikhil
PRESIDENT & CEO, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
169,650
+4%
7,224
$27.69
$199,997.17
BUY
18 Mar 2022
Gassert Chad
SVP - CORP. DEV. & STRATEGY, Officer
ANI PHARMACEUTICALS INC
(ANIP)
393,226
+2%
10,000
$27.51
$275,086.50
BUY
17 Mar 2022
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
18,460
+118%
10,000
$27.65
$276,503.00
BUY
20 Dec 2021
Thoma Jeanne
Director
ANI PHARMACEUTICALS INC
(ANIP)
17,785
+6%
1,072
$46.47
$49,819.59
BUY
7 Dec 2021
Pera Antonio R
Director
ANI PHARMACEUTICALS INC
(ANIP)
19,713
+17%
3,000
$42.26
$126,793.50
BUY
6 Dec 2021
HAUGHEY THOMAS
Director
ANI PHARMACEUTICALS INC
(ANIP)
30,202
+9%
2,500
$39.38
$98,450.00
BUY
15 Mar 2021
Walsh Patrick D
Director
ANI PHARMACEUTICALS INC
(ANIP)
39,096
+11%
4,000
$32.89
$131,555.20
BUY
9 Nov 2020
Walsh Patrick D
Director
ANI PHARMACEUTICALS INC
(ANIP)
35,096
+16%
5,000
$25.96
$129,799.99
BUY
10 Aug 2020
Walsh Patrick D
CHAIRMAN, INTERIM PRES. & CEO, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
23,096
+76%
10,000
$30.78
$307,790.00
BUY
3 Mar 2020
HAUGHEY THOMAS
Director
ANI PHARMACEUTICALS INC
(ANIP)
11,291
+79%
5,000
$45.10
$225,510.00
SELL
19 Aug 2019
MERIDIAN VENTURE PARTNERS II LP
10% Owner
ANI PHARMACEUTICALS INC
(ANIP)
2,219,259
-0%
7,579
$68.21
$516,984.25
SELL
14 Aug 2019
MERIDIAN VENTURE PARTNERS II LP
10% Owner
ANI PHARMACEUTICALS INC
(ANIP)
2,226,838
-2%
62,024
$69.04
$4,282,306.00
SELL
9 Aug 2019
MERIDIAN VENTURE PARTNERS II LP
10% Owner
ANI PHARMACEUTICALS INC
(ANIP)
2,288,862
-2%
61,697
$71.64
$4,419,878.00
BUY
24 May 2019
NASH DAVID
Director
ANI PHARMACEUTICALS INC
(ANIP)
5,236
+38%
1,445
$68.76
$99,358.20
SELL
17 May 2019
Marken James G.
SVP Ops & Prod Dev, Officer
ANI PHARMACEUTICALS INC
(ANIP)
61,230
-12%
8,907
$70.67
$629,457.70
BUY
15 May 2019
HAUGHEY THOMAS
Director
ANI PHARMACEUTICALS INC
(ANIP)
6,291
+65%
2,500
$69.30
$173,240.00
SELL
14 May 2019
Marken James G.
SVP Ops & Prod Dev, Officer
ANI PHARMACEUTICALS INC
(ANIP)
70,137
-6%
4,917
$70.31
$345,714.25
SELL
13 May 2019
PRZYBYL ARTHUR
President and CEO, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
202,589
-12%
30,000
$70.07
$2,102,177.00
SELL
13 May 2019
Schrepfer Robert W
SVP - New Bus Dev & Spec Sales, Officer
ANI PHARMACEUTICALS INC
(ANIP)
55,927
-4%
2,409
$71.13
$171,352.16
SELL
12 Mar 2019
Schrepfer Robert W
SVP - New Bus Dev & Spec Sales, Officer
ANI PHARMACEUTICALS INC
(ANIP)
47,842
-19%
11,796
$64.44
$760,167.70
SELL
14 May 2018
MARSHBANKS TRACY
Director
ANI PHARMACEUTICALS INC
(ANIP)
349,934
-9%
38,236
$62.33
$2,383,192.80
SELL
9 May 2018
MARSHBANKS TRACY
Director
ANI PHARMACEUTICALS INC
(ANIP)
412,399
-13%
62,431
$62.07
$3,874,950.50
SELL
18 Apr 2018
MARSHBANKS TRACY
Director
ANI PHARMACEUTICALS INC
(ANIP)
450,601
-6%
33,200
$62.09
$2,061,388.00
SELL
18 Mar 2018
PRZYBYL ARTHUR
President and CEO, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
205,076
-11%
27,625
$63.53
$1,754,959.80
SELL
15 Mar 2018
RAYNOR DANIEL
Director
ANI PHARMACEUTICALS INC
(ANIP)
289,003
-2%
7,215
$60.85
$439,047.06
SELL
14 Mar 2018
MARSHBANKS TRACY
Director
ANI PHARMACEUTICALS INC
(ANIP)
483,801
-0%
1,912
$63.10
$120,647.20
SELL
12 Mar 2018
RAYNOR DANIEL
Director
ANI PHARMACEUTICALS INC
(ANIP)
296,218
-8%
27,964
$62.24
$1,740,552.00
SELL
12 Mar 2018
PRZYBYL ARTHUR
President and CEO, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
185,706
-17%
40,000
$61.83
$2,473,142.80
SELL
8 Mar 2018
MARSHBANKS TRACY
Director
ANI PHARMACEUTICALS INC
(ANIP)
485,713
-11%
64,221
$63.03
$4,047,887.80
SELL
5 Mar 2018
Marken James G.
SVP Ops & Prod Dev, Officer
ANI PHARMACEUTICALS INC
(ANIP)
65,470
-5%
4,177
$61.92
$258,639.83
SELL
1 Mar 2018
PRZYBYL ARTHUR
President and CEO, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
222,643
-9%
23,986
$61.23
$1,468,694.50
SELL
1 Mar 2018
Schrepfer Robert W
SVP - New Bus Dev & Spec Sales, Officer
ANI PHARMACEUTICALS INC
(ANIP)
36,092
-44%
28,652
$61.66
$1,766,770.90
SELL
22 Aug 2016
PRZYBYL ARTHUR
President and CEO, Director, Officer
ANI PHARMACEUTICALS INC
(ANIP)
191,806
-16%
37,455
$66.97
$2,508,361.50
SELL
8 Aug 2016
Schrepfer Robert W
VP Bus Dev & Con Mfg, Officer
ANI PHARMACEUTICALS INC
(ANIP)
17,362
-41%
12,500
$67.06
$838,208.75
Home